Biotech Sector
NVIDIA's BioNeMo Bets Big on Drug Discovery as Specialized AI Rivals Emerge
ViaNews Editorial Team (Markets)•
#NVIDIA
115 articles
Technology Sector
NVIDIA's BioNeMo Platform Is Building a Pharmaceutical AI Moat — and Investors Should Take Notice
ViaNews Editorial Team (Markets)•
Analysis
NVIDIA Targets Drug Discovery Market With AI Infrastructure Push
ViaNews Editorial Team (Markets)•
Technology
NVIDIA's Lab Robotics Push: AI Partnership Signals Healthcare Pivot
ViaNews Editorial Team (Markets)•
Technology
Alphabet Doubles Capex to $185B: AI Boom for Nvidia, But Risks Mount
ViaNews Editorial Team (Markets)•
Technology
Viking Global Dumps Nvidia and Amazon, Loads Up on Microsoft Stock
ViaNews Editorial Team (Markets)•
Technology
Tech Giants Dominate Retail Investor Portfolios as AI Boom Continues
ViaNews Editorial Team (Markets)•
Technology
Thiel Macro Shifts Focus: Out of Nvidia, Still Bullish on Tesla and Microsoft
ViaNews Editorial Team (Markets)•
Technology
AI Boom Fuels Trillion-Dollar Giants Amidst Bearish Warnings
ViaNews Editorial Team (Markets)•
Technology
Broadcom's AI Chip Business: Growth Potential vs. Market Challenges
ViaNews Editorial Team (Markets)•
Technology
Chamath Palihapitiya Reaps Riches as NVIDIA Acquires Groq for $20.6 Billion
ViaNews Editorial Team (Markets)•